TARDBP and amyotrophic lateral sclerosis: These CDC7 inhibitors effectively reduced TDP-43 phosphorylation in both human cells and an in vivo C. elegans model expressing human TDP-43, with one compound notably decreasing the severity of clinical symptoms in ALS disease models.